DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Glund S, Stangier J, van Ryn J. , et al.
Effect of age and renal function on idarucizumab pharmacokinetics and idarucizumab-mediated reversal of dabigatran anticoagulant activity in a randomized, double-blind, crossover phase Ib study.
Clin Pharmacokinet 2017;
56 (01) 41-54
We do not assume any responsibility for the contents of the web pages of other providers.